|

Vicadrostat Clinical Trials

3 actively recruiting trials across 3 locations

Also known as: BI 690517

Pipeline

Phase 3: 3

Top Sponsors

  • Boehringer Ingelheim3

Indications

  • Heart Disease2
  • Heart Failure2
  • Cardiovascular Diseases1
  • Hypertension1
  • Diabetes1

Anniston, Alabama1 trial

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Pinnacle Research Group, LLC

Phase 3

Birmingham, Alabama1 trial

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

University of Alabama at Birmingham

Phase 3

Mobile, Alabama1 trial

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

Diagnostic and Medical Clinic

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.